Obalon Therapeutics Inc. (OBLN) Declined -5.3% or -0.22 To Price $3.93 On Thursday


Obalon Therapeutics Inc. (OBLN) declined -5.3% or -0.22 to $3.93. It is around 107000 shares traded, which is 22.91% compare to the average total volume 466986. The market cap of OBLN is $68.55 million. The year to date change is -41.96%. The 52 week price range is from $3.4 to $13.18. Price of OBLN have changed 2.22% during last week. It have changed -47.67% over last month, -46.66% over last 3 months, -56.04% over last 6 months and -54.77% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for OBLN is 6.26. It is 59.29% above current price. The 200-day Moving Averages for OBLN is 8.63. It is 119.59% above current price. The 52-week High is 13.18. It is 235.37% from the current price. The 52-week Low is 3.4. It is -13.49% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of OBLN is 0.88 on 2018-01-31. Short % to float is 3.30%. There are some statistics of OBLN. It is has market cap $68.55 million. The share outstanding is 17.44 million. The average volume is 466986. The revenue is 6.99M. It has 256.29M cash and 19.79M in debt. The gross profit is 3.00M. The percent of top 15 Institution holding is 60.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of OBLN is 242.02%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of OBLN is -81.99%.


Tags:

Share this post